Statistics for Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis
Total visits
| views | |
|---|---|
| Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis | 176 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| 40164_2017_Article_92.pdf | 23 |
Top country views
| views | |
|---|---|
| United States | 44 |
| Chile | 35 |
| Germany | 8 |
| Israel | 4 |
| Mexico | 1 |
| Vietnam | 1 |
Top city views
| views | |
|---|---|
| Miami | 37 |
| Santiago | 29 |
| Concepcion | 5 |
| Acre | 4 |
| Alameda | 3 |
| Kempen | 2 |
| Balingen | 1 |
| Campbell | 1 |
| Hanoi | 1 |
| Jacksonville | 1 |
| Lautaro | 1 |
| Los Angeles | 1 |
| Sacramento | 1 |
| Zapopan | 1 |